Nuvectis Pharma (NVCT) Insider Trading & Ownership $8.39 -0.60 (-6.67%) Closing price 04:00 PM EasternExtended Trading$8.38 -0.01 (-0.06%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nuvectis Pharma (NASDAQ:NVCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage35.78%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$1.55 MNumber OfInsiders Selling(Last 12 Months)0 Get NVCT Insider Trade Alerts Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NVCT Insider Buying and Selling by Quarter Nuvectis Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/8/2025Marlio Charles MosseriMajor ShareholderBuy2,650$8.65$22,922.50 5/6/2025Marlio Charles MosseriMajor ShareholderBuy12,444$8.59$106,893.96 2/7/2025Marlio Charles MosseriMajor ShareholderBuy240,000$5.00$1,200,000.00 12/24/2024Ron BentsurCEOBuy4,500$4.65$20,925.00 12/13/2024Marlio Charles MosseriMajor ShareholderBuy17,000$4.70$79,900.00 11/19/2024Enrique PoradosuInsiderBuy2,000$4.99$9,980.00 11/15/2024Ron BentsurCEOBuy20,000$4.92$98,400.00 5/14/2024Ron BentsurCEOBuy1,940$6.74$13,075.60 (Data available from 1/1/2013 forward) NVCT Insider Trading Activity - Frequently Asked Questions Who is on Nuvectis Pharma's Insider Roster? The list of insiders at Nuvectis Pharma includes Enrique Poradosu, Kenneth Hoberman, Marlio Charles Mosseri, Ron Bentsur, and Shay Shemesh. Learn more on insiders at NVCT. What percentage of Nuvectis Pharma stock is owned by insiders? 35.78% of Nuvectis Pharma stock is owned by insiders. Learn more on NVCT's insider holdings. Which Nuvectis Pharma insiders have been buying company stock? The following insiders have purchased NVCT shares in the last 24 months: Enrique Poradosu ($13,125.00), Marlio Charles Mosseri ($4,346,610.60), and Ron Bentsur ($289,662.55). How much insider buying is happening at Nuvectis Pharma? Insiders have purchased a total of 490,955 NVCT shares in the last 24 months for a total of $4,649,398.15 bought. Nuvectis Pharma Key ExecutivesMr. Ron Bentsur M.B.A. (Age 58)Co-Founder, Chairman, CEO & President Compensation: $1.12MDr. Enrique Poradosu Ph.D. (Age 57)Co-Founder, Executive VP, Chief Scientific & Business Officer Compensation: $705.5kMr. Shay Shemesh (Age 40)Co-Founder, Executive VP, Chief Development & Operations Officer Compensation: $705.5kMr. Michael Carson CPA (Age 48)Vice President of Finance More Insider Trading Tools from MarketBeat Related Companies QURE Insider Selling SYRE Insider Selling VIR Insider Selling RCKT Insider Selling NRIX Insider Selling GYRE Insider Selling LENZ Insider Selling NUVB Insider Selling CMRX Insider Selling CDMO Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You? This page (NASDAQ:NVCT) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredDrop these 5 stocks now!You think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
